Kyntra Bio
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,278 | $1,076 | $1,348 | $2,739 |
Gross Profit | 999 | 1,134 | 1,263 | 2,487 |
EBITDA | -9,299 | -10,871 | -11,545 | -14,180 |
EBIT | -9,307 | -11,063 | -11,766 | -14,507 |
Net Income | -14,220 | 200,636 | -7,603 | 4,639 |
Net Change In Cash | 1,278 | 1,076 | 1,348 | 2,739 |
Free Cash Flow | -18,328 | -1,856 | 12,669 | 2,703 |
Cash | 47,872 | 117,975 | 23,367 | 33,609 |
Basic Shares | 4,046 | 4,044 | 4,042 | 100,954 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6,440 | $29,621 | $46,803 | $140,734 |
Gross Profit | 5,884 | 14,060 | 42,841 | 120,454 |
EBITDA | -45,895 | -142,428 | -305,197 | -282,825 |
EBIT | -46,643 | -145,120 | -315,127 | -293,429 |
Net Income | 183,452 | -47,579 | -284,232 | -293,654 |
Net Change In Cash | 6,440 | 29,621 | 46,803 | 140,734 |
Free Cash Flow | -4,812 | -138,265 | -317,540 | -184,674 |
Cash | 47,872 | 50,482 | 113,688 | 155,700 |
Basic Shares | 4,043 | 100,044 | 97,303 | 93,582 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$3.51 |
2025-09-30 | -$3.25 |
2025-06-30 | -$3.39 |
2025-03-31 | $0.05 |
